Aprea Therapeutics, Inc. (APRE)
Nasdaq: APRE · Pharmaceutical Preparations · Doylestown, PA · filing with the SEC since 2019
Who owns Aprea Therapeutics, Inc.
As filed with the SECHolders of 5% or more
3
Vestal Point Capital, LP holds 9.9% of Common Stock, par value $0.001 per share, as its SCHEDULE 13G filed May 15, 2026 says.
Directors and officers
10
report now, of 23 people on the record since 2019. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 3 named at left.
Holders of 5% or moreshare of the class, as filed
Vestal Point Capital, LP
SCHEDULE 13G · filed May 15, 2026 · Common Stock, par value $0.001 per share
Orin Hirschman
SCHEDULE 13G/A · filed Apr 27, 2026 · Common Stock, $0.001 par value per share · 9.9% in Jan 28, 2026
Squadron Master Fund LP
SCHEDULE 13G · filed Apr 7, 2026 · Common Stock
Soleus Private Equity Fund III, L.P.
SCHEDULE 13G · filed Apr 1, 2026 · Common Stock · reported falling below 5%
Nantahala Capital Management, LLC
SCHEDULE 13G/A · filed Feb 13, 2026 · Common stock, par value $0.001 per share · reported falling below 5%, from 7.3% in Nov 14, 2024
Stonepine Capital Management, LLC
SCHEDULE 13G/A · filed May 14, 2025 · Common Stock · reported falling below 5%, from 5.1% in Feb 13, 2025
Lytton Laurence W
SCHEDULE 13G/A · filed Aug 13, 2026 · Common Stock · reported falling below 5%, from 9.9% in Nov 17, 2025
Sio Capital Management, LLC
SCHEDULE 13G/A · filed Nov 12, 2025 · Common stock, par value $0.001 per share · reported falling below 5%, from 5.05% in Aug 13, 2025
What APRE reports owning in othersstakes of 5% or more, and other ties
3 subsidiaries in 2 countries, from the list filed with the 10-K filed Mar 26, 2024.
Insider tradesForm 4
0sales
4purchases
0sales on a scheduled plan
0people selling
$0sold, in dollars
$100,000bought, in dollars
Open-market trades on Form 4 from Sep 30, 2025 to Sep 30, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2026 runs to Sep 30, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window3 of 43 on the roster
| Person | Role as filed | Sales | Sold | On a plan | Buys | Bought |
|---|---|---|---|---|---|---|
| Hamill John P. | SrVP/CFO/Prin Fin & Acct Ofcr | 0 | $0 | 0 | 2 | $0 |
| Gilad Oren | President/CEO | 0 | $0 | 0 | 1 | $0 |
| Duey Marc | director | 0 | $0 | 0 | 1 | $0 |